Loading stock data…
$127.28-0.28 (-0.22%)
Mesa Laboratories, Inc.
Mesa Laboratories, Inc. in the Technology sector is trading at $127.28 with a market capitalization of $708M. Wall Street consensus targets $125.00 (1 analysts), implying a -1.8% move over the next 12 months. The stock is currently 12% below its 52-week high of $144.35, remaining 25.7% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $60.14M↓ | $63.72M↓ | $65.13M↑ | $60.74M↑ | $59.54M |
| Gross Profit | $39.01M↓ | $42.20M↑ | $41.80M↑ | $37.33M↑ | $36.94M |
| Operating Income | $7.03M↑ | $2.75M↓ | $7.97M↑ | $4.72M↑ | $3.06M |
| Net Income | $2.83M↑ | -$4.14M↓ | $3.63M↑ | $2.48M↓ | $4.74M |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control seg...